PIP Search Page

Displaying 381 - 400 of 961

PIPS Search Results
PIP Number	Active Substance	Conditions / Indications	Invented Name	Therapeutic area	Decision Type	Compliance Check	Date Published Sort ascending
MHRA-100950-PIP01-23	lutetium-177 (177Lu) rhPSMA 10.1	Treatment of prostate cancer		Oncology	W: decision granting a waiver in all age groups for the listed condition(s).	No	30/01/2024
MHRA-100872-PIP01-23	pudexacianinium chloride	Visualisation of ureter		Uro-Nephrology Gastroenterology-Hepatology Diagnostic Endocrinology-Gynaecology-Fertility-metabolism Oncology	P: decision agreeing on a paediatric investigation plan, with or without partial waiver(s) or deferrals(s)	No	30/01/2024
MHRA-100866-PIP01-23	obecabtagene autoleucel	Treatment of acute lymphoblastic leukaemia (ALL)		Oncology	P: decision agreeing on a paediatric investigation plan, with or without partial waiver(s) or deferrals(s)	No	30/01/2024
MHRA-100593-PIP01-22	aticaprant	Treatment of Major Depressive Disorder	Not available at present	Psychiatry	P: decision agreeing on a paediatric investigation plan, with or without partial waiver(s) or deferrals(s)	No	30/01/2024
MHRA-101016-PIP01-23	ublituximab	Treatment of multiple sclerosis	Briumvi Briumvi	Neurology	P: decision agreeing on a paediatric investigation plan, with or without partial waiver(s) or deferrals(s)	No	20/12/2023
MHRA-101024-PIP01-23-M01 (update)	gadoquatrane	Diagnosis by evaluation of any known or suspected clinical condition with contrast enhanced magnetic resonance imaging		Diagnostic	PM: decision on the application for modification of an agreed paediatric investigation plan.	No	19/12/2023
MHRA-100932-PIP01-23-M01 (update)	Peanut Flour	Treatment of peanut allergy	Palforzia PALFORZIA Palforzia	Pneumology - Allergology	PM: decision on the application for modification of an agreed paediatric investigation plan.	No	19/12/2023
MHRA-100188-PIP01-21-M02 (update)	lebrikizumab	treatment of atopic dermatitis		Dermatology	PM: decision on the application for modification of an agreed paediatric investigation plan.	No	19/12/2023
MHRA-101028-PIP01-23-M01 (update)	Cholera vaccine, recombinant, live, oral (strain CVD 103-HgR)	Prevention of cholera	Vaxchora	Vaccines	PM: decision on the application for modification of an agreed paediatric investigation plan.	No	19/12/2023
MHRA-101004-PIP01-23-M01 (update)	APIXABAN	Treatment of venous thromboembolism	Eliquis Eliquis Eliquis Eliquis	Cardiovascular Diseases	PM: decision on the application for modification of an agreed paediatric investigation plan.	No	19/12/2023
MHRA-100949-PIP01-23-M01 (update)	Delandistrogene moxeparvovec	Treatment of Duchenne muscular dystrophy	Not available	Neurology	PM: decision on the application for modification of an agreed paediatric investigation plan.	No	19/12/2023
MHRA-100482-PIP01-22-M01 (update)	acetyl-L-leucine ((s)-(acetylamino)-4-methylpentanoic acid)	Treatment of Niemann-Pick disease type C	Not available at present	Neurology	PM: decision on the application for modification of an agreed paediatric investigation plan.	No	19/12/2023
MHRA-100141-PIP01-21-M01 (update)	BENRALIZUMAB	Treatment of Eosinophilic granulomatosis with polyangiitis (EGPA)	FASENRA FASENRA FASENRA FASENRA FASENRA FASENRA FASENRA PEN FASENRA FASENRA PEN	Pneumology - Allergology	PM: decision on the application for modification of an agreed paediatric investigation plan.	No	19/12/2023
MHRA-101188-PIP01-23-M01 (update)	fosdenopterin	Treatment of patients with molybdenum cofactor deficiency (MoCD) Type A	Nulibry	Other: Other alimentary tract and metabolism products, Various alimentary tract and metabolism products	PM: decision on the application for modification of an agreed paediatric investigation plan.	No	19/12/2023
MHRA-101071-PIP01-23-M01 (update)	pegzilarginase	Treatment of hyperargininaemia	Loargys	Endocrinology-Gynaecology-Fertility-metabolism	PM: decision on the application for modification of an agreed paediatric investigation plan.	No	19/12/2023
MHRA-100606-PIP01-22-M01 (update)	sparsentan	Treatment of focal segmental glomerulosclerosis	Filspari Filspari	Uro-Nephrology	PM: decision on the application for modification of an agreed paediatric investigation plan.	No	19/12/2023
MHRA-100253-PIP01-21-M01 (update)	Zuranolone	Treatment of post-partum depression		Psychiatry	PM: decision on the application for modification of an agreed paediatric investigation plan.	No	19/12/2023
MHRA-100043-PIP01-21-M01 (update)	zilucoplan	Treatment of myasthenia gravis	Zilbrysq Zilqivik	Neurology Other: Complement inhibitor for treatment of the autoimmune disease myasthenia gravis	PM: decision on the application for modification of an agreed paediatric investigation plan.	No	19/12/2023
MHRA-100473-PIP01-22-M01 (update)	Recombinant COVID-19 subunit nanoparticle	Prevention of coronavirus disease 2019 (COVID-19)	SKYCovion	Vaccines	PM: decision on the application for modification of an agreed paediatric investigation plan.	No	19/12/2023
MHRA-100982-PIP01-23-M01 (update)	pegunigalsidase alfa	Treatment of Fabry disease	Elfabrio	Endocrinology-Gynaecology-Fertility-metabolism	PM: decision on the application for modification of an agreed paediatric investigation plan.	No	19/12/2023

Download XLSX

Search Filters: